Carolyn M. Gray, Ph.D. - Publications

Affiliations: 
2014 Immunology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Circuits and Computer Engineering

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Liu X, Berry CT, Ruthel G, Madara JJ, MacGillivray K, Gray CM, Madge LA, McCorkell KA, Beiting DP, Hershberg U, May MJ, Freedman BD. T cell receptor-induced NF-κB signaling and transcriptional activation are regulated by STIM1- and Orai1-mediated calcium entry. The Journal of Biological Chemistry. PMID 26826124 DOI: 10.1074/Jbc.M115.713008  0.544
2015 Gray CM, May MJ. Stable reconstitution of IKK-deficient mouse embryonic fibroblasts. Methods in Molecular Biology (Clifton, N.J.). 1280: 181-95. PMID 25736749 DOI: 10.1007/978-1-4939-2422-6_10  0.523
2014 Gray CM, McCorkell KA, Chunduru SK, McKinlay MA, May MJ. Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis. Biochemical and Biophysical Research Communications. 450: 341-6. PMID 24942881 DOI: 10.1016/J.Bbrc.2014.05.122  0.593
2014 Gray CM, Remouchamps C, McCorkell KA, Solt LA, Dejardin E, Orange JS, May MJ. Noncanonical NF-κB signaling is limited by classical NF-κB activity. Science Signaling. 7: ra13. PMID 24497610 DOI: 10.1126/Scisignal.2004557  0.597
2011 Whitmarsh RJ, Gray CM, Gregg B, Christian DA, May MJ, Murray PJ, Hunter CA. A critical role for SOCS3 in innate resistance to Toxoplasma gondii. Cell Host & Microbe. 10: 224-36. PMID 21925110 DOI: 10.1016/J.Chom.2011.07.009  0.474
2011 Neely RJ, Brose MS, Gray CM, McCorkell KA, Leibowitz JM, Ma C, Rothstein JL, May MJ. The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK. Oncogene. 30: 87-96. PMID 20818435 DOI: 10.1038/Onc.2010.396  0.584
Show low-probability matches.